Hepatocellular carcinoma in Fontan-associated liver disease: Incidence, risk stratification, and surveillance implications
Open Access
- 26 February 2026
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology Communications
- Vol. 10 (3)
Abstract
Background: Hepatocellular carcinoma (HCC) is a serious complication of Fontan-associated liver disease (FALD). However, data on its incidence, risk factors, and outcomes in this rare population are limited. We aimed to assess the incidence and predictors of HCC and evaluate the utility of surveillance in patients with FALD. Methods: We conducted a retrospective cohort study on patients with FALD who were referred to our gastroenterology department. The cumulative incidence of HCC after FALD diagnosis was calculated, and multivariate analysis was used to identify independent risk factors. Overall survival after FALD diagnosis was compared between patients who developed HCC and those who did not. Results: A total of 120 patients with FALD were followed up for a median period of 50.0 months. The cumulative incidence rates of HCC at 1, 2, and 3 years after FALD diagnosis were 0.9%, 2.7%, and 3.9%, respectively. Elevated alpha-fetoprotein (AFP) at FALD diagnosis was independently associated with HCC development (hazard ratio, 1.29; 95% confidence interval, 1.04–1.60; p =0.01). There was no significant difference in overall survival between patients with and without HCC in this cohort (log-rank test, p =0.50). Conclusions: Patients with FALD face a non-negligible risk of developing HCC, thus supporting the need for surveillance. Elevated AFP levels at the time of FALD diagnosis may aid in risk stratification, which enables the targeted monitoring and early detection of HCC. Furthermore, routine surveillance contributes to the excellent prognosis of patients with FALD who develop HCC, thus making their prognosis comparable to that of patients without HCC.Keywords
This publication has 24 references indexed in Scilit:
- Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk PatientsRadiology, 2018
- Identification of liver fibrosis using the hepatic vein waveform in patients with Fontan circulationHepatology Research, 2018
- Abdominal Imaging Surveillance in Adult Patients After Fontan Procedure: Risk of Chronic Liver Disease and Hepatocellular CarcinomaCurrent Problems in Diagnostic Radiology, 2018
- Abnormality of the hepatic vein waveforms in cirrhotic patients with portal hypertension and its prognostic implicationsJournal of Gastroenterology and Hepatology, 2008
- Long-Term Survival, Modes of Death, and Predictors of Mortality in Patients With Fontan SurgeryCirculation, 2008
- The Fontan ProcedureCirculation, 2007
- MELD-XI: A rational approach to “sickest first” liver transplantation in cirrhotic patients requiring anticoagulant therapyLiver Transplantation, 2006
- Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfectionHepatology, 2006
- Progression of liver pathology in patients undergoing the Fontan procedure: Chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinomaThe Journal of Thoracic and Cardiovascular Surgery, 2005
- Early detection of hepatocellular carcinoma in patients with chronic type B hepatitisGastroenterology, 1986